The price of Teva Pharmaceutical stock has seen a fall of 17% in a month, while it is down 34% in the last year. The shares of generic drug makers have largely underperformed the broader markets over the last year or so, primarily due to concerns around the pricing environment and liabilities...
The price of Teva Pharmaceutical stock has seen a fall of 17% in a month, while it is down 34% in the last year. The shares of generic drug makers have largely underperformed the broader markets over the last year or so, primarily due to concerns around the pricing environment and liabilities...
Share this Article
Recommended